
ABOUT US
Beantown Biotech
Established in 2012, Beantown Biotech was founded on the idea that outsourcing the drug discovery process should be a dynamic relationship between a CRO and a client. We strive for a quick turnaround of data and maintain an open line of communication with our clients to ensure no detail is overlooked. The scientists at Beantown Biotech have your best interests at heart and we want you to consider our lab as an extension of your company. In 2021, we moved to Billerica, Massachusetts into a 6,000 square foot facility and we are open for in-person client visits. It is our core belief that excellent science requires open dialogue, accountability, and reliable results.

Senior Leadership

Jim Breunig
CEO & Founder

Phil Bergman
CSO

Rachel
Mendes
Sr. Director of Business Development & Strategy
Our Team
.jpg)
Kseniia Chudakova

Sarah
Means

Danielle
Sorenson

Lars
Hanson

Colin
Nash
.jpg)
Taylor Ventura
.jpg)
Audrey Johnson

Evelyn
Ostrowsky


Top 10 Preeminent CRO 2023, Awarded by Life Sciences Review
“The all-around capabilities of Beantown Biotech make it an ideal partner for biotechnology companies seeking to propel their early-stage drug candidates toward optimal outcomes for research projects.”
